Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitions.
Benedikt HoehCristina Cano GarciaSeverine BanekNiklas KlümperAlexander CoxJoerg EllingerPhilipp SchmuckerOliver HahnAngelika MattigkFriedemann ZengerlingPhilippe BeckerKati ErdmannBjoern Thorben BuerkLuka FlegarJohannes HuberCharis KalogirouPhilip ZeuschnerPublished in: Clinical & translational immunology (2023)
Different early CRP kinetics may predict therapy response in first-line mRCC therapy in a large real-world cohort. However, further research regarding the optimal timing and frequency of measurement is needed.